Stille

Stille CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Stille (STIL.ST) as of Oct 24, 2026 is 57.12 %. In the previous year, CapEx to Operating Cash Flow Ratio was 19.44 % — a change of 193.82% (higher).

CapEx/OCF

57.12 %

YoY

193.82%

Last updated:

CapEx to Operating Cash Flow Ratio of Stille is 2025 57.12 % . CapEx to Operating Cash Flow Ratio of Stille was 2024 19.44 % . It decreases by 193.82% higher compared to the previous year.

The Stille CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
33.23 SEK
Jan 1, 2019
30.51 SEK
Jan 1, 2020
114.05 SEK
Jan 1, 2021
261.36 SEK
Jan 1, 2022
25.18 SEK
Jan 1, 2023
34.61 SEK
Jan 1, 2024
19.44 SEK
Jan 1, 2025
57.12 SEK
The Stille CapEx/OCF history
YEARCapEx/OCFYoY
57.12 %+193.82%
19.44 %-43.83%
34.61 %+37.46%
25.18 %-90.37%
261.36 %+129.17%
114.05 %+273.76%
30.51 %-8.17%
33.23 %+269.90%
8.98 %+14.36%
7.86 %-40.37%
13.17 %-107.21%
-182.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

CapEx to Operating Cash Flow Ratio of Stille is 57.12 % in 2025.

CapEx to Operating Cash Flow Ratio of Stille changed from 19.44 % to 57.12 %, representing a 193.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Stille since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Stille with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Stille

All Key Metrics — Stille